Aslan Pharmaceuticals Price Prediction
| ASLNDelisted Stock | USD 0.60 0.03 4.76% |
Oversold Vs Overbought
25
Oversold | Overbought |
Using Aslan Pharmaceuticals hype-based prediction, you can estimate the value of Aslan Pharmaceuticals from the perspective of Aslan Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Aslan Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Aslan because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Aslan Pharmaceuticals after-hype prediction price | USD 0.6 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Aslan |
Aslan Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Aslan Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Aslan Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Aslan Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Aslan Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Aslan Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Aslan Pharmaceuticals' historical news coverage. Aslan Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.60 and 0.60, respectively. We have considered Aslan Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Aslan Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Aslan Pharmaceuticals is based on 3 months time horizon.
Aslan Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Aslan Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aslan Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Aslan Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 8 Events / Month | 17 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.60 | 0.60 | 0.00 |
|
Aslan Pharmaceuticals Hype Timeline
Aslan Pharmaceuticals is presently traded for 0.60. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Aslan is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is presently at 0.0%. %. The volatility of related hype on Aslan Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 0.60. About 13.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 16.0. Aslan Pharmaceuticals had not issued any dividends in recent years. The entity had 1:8 split on the 3rd of July 2024. Given the investment horizon of 90 days the next expected press release will be in about 8 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.Aslan Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Aslan Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Aslan Pharmaceuticals' future price movements. Getting to know how Aslan Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Aslan Pharmaceuticals may potentially react to the hype associated with one of its peers.
Aslan Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Aslan price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aslan using various technical indicators. When you analyze Aslan charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Aslan Pharmaceuticals Predictive Indicators
The successful prediction of Aslan Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Aslan Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Aslan Pharmaceuticals based on analysis of Aslan Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Aslan Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Aslan Pharmaceuticals's related companies.
Story Coverage note for Aslan Pharmaceuticals
The number of cover stories for Aslan Pharmaceuticals depends on current market conditions and Aslan Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Aslan Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Aslan Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Aslan Pharmaceuticals Short Properties
Aslan Pharmaceuticals' future price predictability will typically decrease when Aslan Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Aslan Pharmaceuticals often depends not only on the future outlook of the potential Aslan Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aslan Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 16.4 M | |
| Cash And Short Term Investments | 21.3 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Aslan Stock
If you are still planning to invest in Aslan Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aslan Pharmaceuticals' history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |